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Abstract
Background: Opportunities for community members to actively participate in policy 
development are increasing. Community/citizen’s juries (CJs) are a deliberative demo-
cratic process aimed to illicit informed community perspectives on difficult topics. But 
how comprehensive these processes are reported in peer- reviewed literature is un-
known. Adequate reporting of methodology enables others to judge process quality, 
compare outcomes, facilitate critical reflection and potentially repeat a process. We 
aimed to identify important elements for reporting CJs, to develop an initial checklist 
and to review published health and health policy CJs to examine reporting standards.
Design: Using the literature and expertise from CJ researchers and policy advisors, a 
list of important CJ reporting items was suggested and further refined. We then re-
viewed published CJs within the health literature and used the checklist to assess the 
comprehensiveness of reporting.
Results: CJCheck was developed and examined reporting of CJ planning, juror informa-
tion, procedures and scheduling. We screened 1711 studies and extracted data from 38. 
No studies fully reported the checklist items. The item most consistently reported was 
juror numbers (92%, 35/38), while least reported was the availability of expert presenta-
tions (5%, 2/38). Recruitment strategies were described in 66% of studies (25/38); how-
ever, the frequency and timing of deliberations was inadequately described (29%, 11/38).
Conclusions: Currently CJ publications in health and health policy literature are inad-
equately reported, hampering their use in policy making. We propose broadening the 
CJCheck by creating a reporting standards template in collaboration with international 
CJ researchers, policy advisors and consumer representatives to ensure standardized, 
systematic and transparent reporting.
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1  | BACKGROUND
It is incumbent on researchers to provide adequate descriptions of their 
research methodology and methods when reporting their findings in the 
peer- reviewed literature. Where research methods are well described, 
we better understand the process by which the findings have been gen-
erated and have more confidence in appraising the credibility of these 
outcomes. Reporting standards also create an incentive for researchers 
to be meticulous in designing studies. Reporting guidelines have been 
developed for a range of methods and disciplines for these reasons (e.g. 
CONSORT, PRISMA, STARD,1 CHEERS2) and some journals now require 
these checklists to be completed prior to publication. More recently, 
templates have been developed to provide guidance for describing the 
interventions tested in research (TIDieR3). When used, these checklists 
allow comparisons between studies, enhance transparency, support 
trust in the process and provide robust foundations for future research.
In Western liberal democracies, there has been an increased open-
ness in government public policy processes to include public voices in 
policy debate and formulation.4–6 Public engagement processes are 
gaining popularity, but their methods vary.4,7 Three broad methods 
of public engagement include communicative (e.g. public meetings, 
website information), consultative (e.g. opinion poll, focus groups) and 
participatory (deliberative poll, citizen jury).8 This article is focused 
on a group of participatory, deliberative democratic processes with 
 methodologies similar to those described by the Jefferson Center.9 
Some have been called citizens’ panels, citizens’ fora and community/
citizens’ jury. We refer to these, collectively, as community juries (CJs).
As a participatory form of public engagement, CJs aim to illicit an in-
formed community perspective on controversial or difficult topics where the 
values and preferences of community members are sought. For this reason, 
CJ participants are recruited from the general population and deliberate 
on questions that require an ethically sensitive or value- based decision. 
Common CJ elements include extensive provision of information from ex-
pert presentations, questioning opportunities, substantial time for delibera-
tion and formulation of a consensus or majority “verdict” by CJ participants.9
CJs have been used to explore community perspectives on several 
health areas including screening,10–12 resource priority setting,13,14 
informed consent processes for screening decisions15 and pandemic 
planning.16 These particular examples were conducted for research 
purposes and none formally linked CJ outcomes to policy decisions. 
But in Australia, the extent to which CJs are embedded in policy pro-
cesses is changing. Recently, CJs have been used by local and pro-
vincial governments to garner public input to policy making.17–19 
However, despite the increased use in policy decision making, some 
hesitancy exists around the trustworthiness of CJ processes.20 If the 
process methods of CJs were reported comprehensively, consistently 
and transparently, their use in shaping health policy may increase.
Over a decade has passed since Abelson et al.4 suggested design 
and evaluation principles for public deliberations. Four key components 
were identified: representation of citizenry, documentation of deliber-
ative procedures, descriptions of information provided to community 
members and reporting of outcomes. However, inconsistencies in re-
porting of these components still occur. A recent systematic review 
explored the adaptations in CJ methodologies and reported wide vari-
ations in how CJs were conducted and reported.21 Also, in a review of 
public deliberation in health policy, Abelson et al.5 continued to find in-
consistencies and ambiguity in reporting method descriptions. Different 
CJs could legitimately have different outcomes even if they followed the 
same methodology (random recruitment, same expert information, etc.), 
but poor and/or inconsistent reporting means it is difficult to compare 
CJ findings or consider potential reasons for differing results, and it is not 
yet empirically clear how methodological variation may alter outcomes.
We cannot assess quality until we are clear about methodology. 
Implementers of CJs know little about what might enhance or detract 
from the legitimacy of claims about the representation of different types 
of public; quality of the processes of information provision and public delib-
eration; or the authenticity of the outcomes. We sought to determine the 
adequacy of process reporting in CJs published in the peer- reviewed health 
and health policy literature. We used two processes. First, we conducted 
a Delphi survey with a group of published CJ researchers to generate an 
agreed checklist of CJ characteristics and research methods that are im-
portant to report in publications. Second, using this checklist, we then re-
viewed published CJs to establish the utility of the checklist and determine 
the most frequently reported and missing descriptions of the CJ methods.
2  | METHODOLOGY
2.1 | Stage 1: initial CJCheck development
Fourteen published Australian CJ researchers and selected govern-
ment policy advisors attended a CJ Research Symposium at Bond 
University, Australia, in July 2015. Participants were invited if they 
were active Australian CJ researchers (13 invited, 10 attended); ac-
tive policy advisors/government workers (four invited, all attended or 
were represented); and/or consumer representatives (two invited and 
neither able to attend). Symposium goals were broad with an aim to 
discuss several key research and policy questions. Outcomes included 
the identification of several research agenda and collaborative links. 
One research question arising from the symposium was to identify 
potentially important CJ characteristics and processes and determine 
whether these were reported in published CJ studies. Methodological 
elements of CJs were brainstormed and iteratively developed by 
all symposium participants in small group, round robin exercises. 
A smaller self- selected working party (from the larger symposium 
group) participated in a two- stage Delphi method22 to refine these 
CJ elements.
The first Delphi round was conducted in September 2015. The sur-
vey consisted of the 17 reportable methods suggested by the larger CJ 
symposium group. These criteria were divided into four groups (planning 
the CJ, characteristics of the jurors, CJ procedures and CJ schedule). 
Respondents were asked to rate each criterion on a five- point Likert 
scale (1=“important” to 5=“unimportant”). Changes to item wording and 
new items could be suggested for ranking in the second round. Items that 
were scored by six or more respondents as “important” or “somewhat 
important” were retained. Items that had fewer than five respondents 
scoring in these top two categories were re- ranked in the second round.
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The second round was conducted in October 2015. Questions 
were again ranked on a five- point Likert scale. As before, there was 
one optional, free response question, for further suggestions. On this 
occasion, respondents were also asked whether the item was import-
ant but not necessary to report.
The final checklist (CJCheck) was used in data extraction. Seven 
items were rated as either “yes” or “no,” while the remainder as “yes,” 
“no” or “unclear.” Specific checklist criteria are reported in Table S1.
2.2 | Stage 2: selection of CJ studies and data extraction
We used two strategies to search for included studies. First, included 
articles were drawn from two recent systematic reviews pertaining 
to deliberative democracy.21,23 These systematic reviews included a 
broad range of deliberative democratic techniques; therefore, we only 
included articles from these reviews that nominated the deliberative 
democratic technique most resembling CJs (e.g. random or represent-
ative selection of jurors, provision of balanced information to jurors, 
sufficient time allocated to deliberation).8 Included studies from these 
two reviews described the deliberative process as “citizens’ panels,” 
“community or citizens’ juries,” “citizens’ council” or “citizens’ fora”).
In addition to including relevant studies from the two previous re-
views, we replicated the search strategy of Degeling et al.23 and mod-
ified the search dates to encompass 2013 to 2015 to include studies 
published since the initial search. We conducted the new search in 
Medline, Web of Science, Current Contents Connect and Scopus data-
bases in September 2015. Therefore by combining the two search 
strategies, we included published CJ studies in the health and health 
policy literature between 1996 and September 2015.
Remaining consistent with others,9,21,23 we included studies that de-
scribed the deliberative process as having characteristics similar to CJs. 
Our inclusion criteria required studies to describe any or some charac-
teristics resembling those outlined by the Jefferson Centre9 regardless of 
whether they were reported in detail. For example, studies were required 
to define themselves as conducting a citizen jury, community jury, citizen 
panel or fora, providing information to participants from different “ex-
perts” and having a deliberative component.9 Protocols were excluded. 
All studies were screened independently against eligibility criteria by two 
authors (R.T. and R.S.). Conflicts were checked periodically and resolved 
through discussion. Criteria definitions were clarified where necessary.
2.3 | Data analysis
Data extraction was conducted by the same two authors using the 
checklist developed in the Delphi rounds. Data were analysed descrip-
tively using Excel.
3  | RESULTS
3.1 | Stage 1: initial CJCheck development
In the first Delphi round, 13 CJ methodology reporting criteria were 
identified as either important or somewhat important and retained. In 
the second Delphi round, nine items were presented: four from round 
one that required further ranking and five new items. Following the 
second round, a further three questions were indicated to be impor-
tant in the reporting of CJs and were retained, two were combined 
with other retained items, one item was reworded and retained and 
three were excluded. The Delphi round outcomes are reported in 
Table 1. No items were consistently ranked as “somewhat unimpor-
tant” or “unimportant.”
Six checklist items were rated higher in importance than others. To 
be designated as an important item, it had to be rated either important 
or somewhat important by a clear majority of respondents (8/8 respon-
dents in the first round and 8/9 respondents in the second round).
The final checklist contained 17 items grouped into four areas: 
planning of the CJ; juror information and characteristics; procedural 
information; and the scheduling of CJs.
3.2 | Stage 2: adequacy of CJ method reporting
From the two systematic reviews,21,23 45 studies were excluded be-
cause they were not described as a CJ and 22 studies were reported 
in both reviews, leaving a total of 46 studies for full- text review. In ad-
dition to these, our focused literature search modified from Degeling 
et al.23 found 1598 de- duplicated articles for further analysis, of 
which only 18 met the inclusion criteria and were included in full- text 
review and data extraction. We excluded 26 full- text articles from 
data extraction, leaving 38 studies in our final analyses (see Fig. 1). 
Included studies and their characteristics are listed in Table 2, with 
data extraction details of included studies available in Table S2 and 
reason for study exclusion from full- text review provided in Table S3.
Studies varied widely in their reporting of the methodological pro-
cesses necessary for reliable CJ reproduction. No study reported all 17 
checklist items. On average, only 53% of checklist items (nine items 
from a possible 17) were reported in any given article (SD=19.5%) 
and this proportion ranged from 12% (2/17 items13) to 88% (15/17 
items24). Overall, the checklist item reported most consistently was 
“Was the number of jurors reported” (92%, 35/38 studies). In contrast, 
the least reported item was “Are the expert presentations available,” 
which was only reported in 5% (2/38 studies) of articles. Figure 2 
shows the proportion of articles reporting checklist items.
3.3 | Planning the CJ
When reporting about planning a CJ, 21% (8/38) of studies described 
whether they had a stakeholder group or committee and if so, the 
role of this group in CJ planning. Less than half (45%, 17/38) stated 
how and why the experts were chosen; however, more (58%, 22/38) 
defined the roles of the experts and most (89%, 34/38) gave a clear 
description of the jury “charge.”
3.4 | Information about the jurors
The majority of studies reported some type of juror information. The 
recruitment strategy was described in 66% (25/38) of studies and 
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TABLE  1 Ranking outcomes of Delphi rounds 1 and 2
Checklist items
Ranking of Delphi respondents
Important
Somewhat 
important OK
Somewhat 
unimportant Unimportant
Important, but not 
necessary to report
Round 1 (N=8)
Planning Was the stakeholder/committee’s role clearly 
described?
4 2 1 1 0 NA
Was the selection of experts (who was chosen 
and why) adequately described?
4 3 1 0 0 NA
Were the experts roles clearly defined? 5 3 0 0 0 NA
Was the Jury “charge” or instruction clearly 
described?
6 2 0 0 0 NA
Jurors Was the study recruitment strategy clearly 
described?
6 2 0 0 0 NA
Were inclusion/exclusion criteria reported? 7 1 0 0 0 NA
Was the type of participant/juror described 
(unaffected public, affected public, advocate)?
6 1 1 0 0 NA
Were the demographics of the jurors reported 
(age, gender, education, attainment)?
3 4 1 0 0 NA
Procedure Was the role and experience of the facilitator 
described (e.g. impartial, informed, member of 
research team, independent)?
2 2 4 0 0 NA
Were materials provided to the jurors 
adequately described and accessible?
5 2 1 0 0 NA
Was the expert cross- examination opportuni-
ties described?
2 5 1 0 0 NA
Was the jury outcome reported? 6 0 1 0 1 NA
Scheduling Was the schedule (how often and interval) and 
length (days/hours) of juror meetings 
reported?
6 2 0 0 0 NA
Was the daily schedule of events described? 1 4 3 0 0 NA
Was the number of presenters and their topics 
described?
4 2 2 0 0 NA
Are the expert presentations available? 2 3 3 0 0 NA
Were the lengths of the presentations 
reported?
0 4 2 2 0 NA
New items 
suggested 
from 
Round 1
Were the jurors paid? – – – – – NA
How many jurors were there? – – – – – NA
What was the influence of the jury outcome on 
policy?
– – – – – NA
What was the framing/nature of jury 
deliberations?
– – – – – NA
What was the influence of the commissioning 
body on the jurors?
– – – – – NA
Round 2 (N=9)
Re- ranked 
from 
Round 1
Was the role and experience of the facilitator 
described (e.g. impartial, informed, member of 
research team, independent)?
3 4 0 2 0 0
Was the schedule (how often and interval) and 
length (days/hours) of juror meetings 
reported?
4 4 1 0 0 0
Are the expert presentations available? 3 4 1 0 0 1
Were the lengths of the presentations reported? 2 1 5 0 0 1
(Continues)
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inclusion and exclusion criteria were described in 58% (22/38). Whether 
the juror was an affected member of the public, unaffected member 
of the public, advocate or invited via random sampling was reported 
in 79% (30/38) of studies. However, only just over half (58%, 22/38) 
reported the demographic characteristics of the jurors. The most con-
sistently reported juror detail was the number of jurors (92%, 35/38).
Checklist items
Ranking of Delphi respondents
Important
Somewhat 
important OK
Somewhat 
unimportant Unimportant
Important, but not 
necessary to report
New items 
suggested 
from 
Round 1: 
to rank
Were the jurors paid? 2 1 3 3 0 0
How many jurors were there? 6 2 1 0 0 0
What was the influence of the jury outcome on 
policy?
1 3 1 2 1 1
What was the framing/nature of jury 
deliberations?
5 1 2 0 0 0
What was the influence of the commissioning 
body on the jurors?
2 3 0 2 1 1
TABLE  1  (Continued)
F IGURE  1 PRISMA flow chart
Street and Degeling
(N = 113)
Excluded: Not
described as CJ in
review
(n = 45)
Excluded (n = 1569)Less Duplicates
(N = 46)
Full Text Assessed for
Eligibility
(N = 29)
Included in Data Extraction
(N = 64)
Excluded (n = 11)
Excluded (N = 26)
- Not Original Study (n = 6)
- Not CJ (n = 5)
- Length (n = 4)
- Not Health Topic (n = 3)
- Protocol (n = 2)
- Secondary Analysis (n = 2)
- Multiple Reasons (n = 2)
- Number of Participants (n = 1)
- Case Study (n = 1)
Search Results
(N = 3181)
Less Duplicates
(N = 1598)
Eligible Articles
(N = 18)
Excluded: (N = 22)
- Not Original Study (N = 13)
- Not CJ (n = 5)
- Length (n = 4)
Excluded (n = 1583)
Included in Final Analysis
(N = 38)
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3.5 | Procedural information
There was a wide variation in what procedural information was pro-
vided in the published studies. The role and experience of the facili-
tator was described in less than half (45%, 17/38) of the examined 
studies. There was an absence of description and accessibility of ma-
terials provided to the jurors, with this reported in only 26% (10/38) 
of studies. Approximately 68% (26/38) described the expert cross- 
examination opportunity provided to the jurors. The outcome of juries 
was the most consistently reported criterion in this section with 84% 
(32/38) reporting this outcome. But only 47% (18/38) described how 
the jurors were instructed to deliberate.
3.6 | CJ scheduling information
Overall, CJ scheduling information was poorly reported. The fre-
quency and timing of deliberations was reported in only 29% (11/38) 
of examined studies. The number of presenters and their topics was 
reported less than half the time (45%, 17/38) and the availability of 
expert presentations was reported in only 5% of studies (2/38).
4  | DISCUSSION
Overall, our findings indicate considerable opportunity for improve-
ment in the reporting of CJs. No published CJs we assessed fully 
described CJCheck items identified by CJ researchers as important 
to report. Less than half of the studies in our analyses reported the 
role of the stakeholder committee; how and why experts were se-
lected; the role of the facilitator; a description of the materials pro-
vided to the jurors; how the deliberations were framed; the scheduling 
of events; the number of presenters and their topics; and whether 
the expert presentations were available. The most reported checklist 
items were the number of jurors, a description of the jury charge and 
the jury outcome. Although these are essential reporting items, they 
are not sufficient.
Although in this review we have focused on peer- reviewed publi-
cations, we believe our suggested checklist items apply to all reported 
CJs. CJ organizers need to be sufficiently transparent and rigorous in 
reporting their methods for several reasons: leaving open the possibil-
ity of attempting to approximate and repeat a CJ elsewhere; enabling 
judgements about the quality of the CJ process; allowing comparison 
of juries; and facilitating critical reflection on CJ design and its poten-
tial effect on CJ outcomes. We cannot do this if authors inconsistently 
report methodology and methods.
It is not our contention that if a particular CJ was repeated that 
the CJ “verdict” and reasoning would necessarily be the same. It is 
feasible that it might not be, given different contexts and partici-
pants and therefore different values and preferences. But it is also 
feasible that repeating a CJ, with different participants but the same 
content and processes, may produce similar outcomes. Because CJ 
methods are not currently consistently reported, we cannot assess 
F IGURE  2 The number of included studies with rating descriptions of checklist items. *Indicates items identified by Delphi respondents as 
important
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these questions. Perhaps more importantly, comprehensive reporting 
of CJs supports transparency and would permit the improved evalu-
ation of CJ methodologies. How representative, procedurally fair and 
accountable CJs are in the health sector has not been fully evalu-
ated.4,21 This hampers the utility of CJs to contribute to important 
health policy debates.
Our study has numerous strengths and some limitations. We con-
ducted a focused review of published CJ studies within the health sec-
tor and mapped descriptions of their methods to criteria developed by 
CJ researchers. The criteria checklist had two rounds of iterations by 
published CJ authors to ensure that important methodology and pro-
cesses were captured. Studies were then independently rated using 
these criteria for completeness of reporting. However, the criteria may 
be somewhat limited as they were developed by a group of Australian 
CJ researchers and policy advisors and may not reflect the wider view 
of other CJ organizers. We consider this an important future develop-
ment. Additionally, we rated the adequacy of reporting on the basis 
of the written publication and did not contact the authors for further 
information. This was a deliberate choice, as our purpose was to assess 
the adequacy of reporting of published CJs.
Other CJ research has reported the variations in methodol-
ogy.5,21,23 This was the first study to quantify those variations by 
mapping researcher- identified methodological reporting criteria. 
Our process was similar to the initial development of the TIDieR 
checklist,25 the uptake of which seems likely to strengthen the util-
ity of intervention research. We intend to expand our consortium 
of CJ researchers, policy advisors and consumer representatives to 
develop an internationally agreed CJ reporting template. We expect 
that the legitimization of CJs’ input into public health policies will be 
assisted by the use of standards for reporting of methodology and 
methods.
5  | CONCLUSION
To fully report processes within a CJ, it is important that the plan-
ning of the event, information about the jurors and their recruitment, 
and procedural and technical information be available and clearly 
documented. Our findings suggest that many current CJ publica-
tions in health and health policy literature are inadequately reported. 
Therefore, methods are not transparent and readers cannot compare 
CJ processes and outcomes. This may not be solely a result of inad-
equate reporting, but also due to the absence of specific reporting 
standards for CJs.
Street et al.21 suggested that strict adherence to CJ methodol-
ogy as described by the originators might limit the generation of new 
knowledge. We agree. We advocate that CJ organizers and authors be 
committed to rigour and openness, but also innovation. It is through 
testing and adapting methodologies that new ideas are developed and 
understanding expands. As researchers who utilize CJ methodology, 
it is not our intention to restrict methodological development, but to 
enhance understanding. In this study, we present an empirically de-
veloped and trialled, proposed checklist for reporting CJ methodology 
and methods. We advocate broadening CJCheck by creating a report-
ing standards template developed by a consortium of international CJ 
researchers, health policy advisors and consumer representatives to 
use when designing and reporting CJs.
CONFLICT OF INTEREST
The authors report no conflicts of interest.
FUNDING SUPPORT
RT was supported by a NHMRC Screening and Test Evaluation 
Program (STEP) Grant (#633033). RS was supported by a Bond 
University Vice Chancellor’s Research Grant Scheme. CD, SMC and LR 
received funding support from NHMRC Project Grant (#1023197). CD 
received funding support from a NHMRC Project Grant (#1083079). 
SMC is funded through NHMRC Career Development Fellowship 
(#1032963). JMS was funded by an Australian National Preventive 
Health Agency Fellowship (20STR2013F) and an NHMRC Capacity 
Building Grant (565501).
REFERENCES
 1. Simera I, Altman DG. Writing a research article that is “fit for pur-
pose”: EQUATOR Network and reporting guidelines. Evid Based Med. 
2009;14:132–134.
 2. Husereau D, Drummond M, Carswell C, et al. Consolidated health 
economic evaluation reporting standards (CHEERS) statement. BMJ. 
2013;346:f1049.
 3. Hoffmann TC, Glasziou P, Boutron I, et al. Better reporting of in-
terventions: template for intervention description and replication 
(TIDieR) checklist and guide. BMJ. 2014;348:g1687.
 4. Abelson J, Forest PG, Eyles J, Smith P, Martin E, Gauvin FP. Deliberations 
about deliberative methods: issues in the design and evaluation of 
public participation processes. Soc Sci Med. 2003;57:239–251.
 5. Abelson J, Blacksher EA, Li KK, Boesveld SE, Goold SD. Public 
deliberation in health policy and bioethics: mapping an emerg-
ing, interdisciplinary field. J Public Deliberation. 2013;9: Article 5. 
Available at: http://www.publicdeliberation.net/cgi/viewcontent.cgi? 
article=1256&context=jpd.
 6. Barnes M, Newman J, Sullivan HC. Power, Participation and Political 
Renewal: Case Studies in Public Participation. Bristol: The Policy Press; 2007.
 7. Whitty JA. An international survey of the public engagement prac-
tices of health technology assessment organisations. Value Health. 
2013;16:155–163.
 8. Mitton C, Smith N, Peacock S, Evoy B, Abelson J. Public participa-
tion in health care priority setting: a scoping review. Health Policy. 
2009;91:219–228.
 9. The Jefferson Center. Citizens Jury Handbook. Washington, DC: 2004. 
Available at: http://www.epfound.ge/files/citizens_jury_handbook.
pdf Accessed August 22, 2016.
 10. Thomas R, Glasziou P, Rychetnik L, Mackenzie G, Gardiner R, Doust J. 
Deliberative democracy and cancer screening consent: a randomized 
control trial of the effect of a community jury on men’s knowledge 
about and intentions to participate in PSA screening. BMJ Open. 
2014;4:e005691.
 11. Paul C, Nicholls R, Priest P, McGee R. Making policy decisions about 
population screening for breast cancer: the role of citizens’ delibera-
tion. Health Policy. 2008;85:314–320.
636  |     Thomas eT al.
 12. Mosconi P, Castellani C, Villani W, Satolli R. Cystic fibrosis: to screen 
or not to screen? Involving a citizens’ jury in decisions on screening 
carrier. Health Expect. 2014;18:1956–1967.
 13. Gooberman-Hill R, Horwood J, Calnan M. Citizens’ juries in planning 
research priorities: process, engagement and outcome. Health Expect. 
2008;11:272–281.
 14. Street J, Callaghan P, Braunack-Mayer AJ, Hiller JE. Citizens’ perspec-
tives on disinvestment from publicly funded pathology tests: a delib-
erative forum. Value Health. 2015;18:1050–1056.
 15. Degeling C, Rychetnik L, Pickles K, et al. “What should happen before 
asymptomatic men decide whether or not to have a PSA test?” A re-
port on three community juries. Med J Aust. 2015;8:335.e1–335.e6.
 16. Braunack-Mayer AJ, Street JM, Rodgers WA, Givney R, Moss JR, 
Hiller JE, Flu Views team. Including the public in pandemic planning: 
a deliberative approach. BMC Public Health. 2010;10:501–510.
 17. Clear Horizon Consulting. Evaluation – community engagement process 
for the 10 year financial plan. Clear Horizon ref no CH14_154. 2015. 
http://participate.melbourne.vic.gov.au/application/files/3514/ 
4477/8217/Evaluation_of_ community_engagement_for_the_10_Year_ 
Financial_Plan.pdf. Accessed March 4, 2016.
 18. Department of Premier and Cabinet, South Australian Government. 
Your Say website. http://yoursay.sa.gov.au/initiatives/citizens-jury. 
 Accessed March 4, 2016.
 19. Hawkes N. Women, “jurors” are asked how to present risk- benefit 
ratio of breast cancer screening. BMJ. 2012;345:e7886.
 20. Boswell J, Settle C, Dugdale A. Who speaks, and in what voice? The 
challenge of engaging ‘the public’ in health policy decision- making. 
Public Manage Rev. 2015;17:1358–1374.
 21. Street J, Duszynski K, Krawczyk S, Braunack-Mayer A. The use of citi-
zens’ juries in health policy decision- making: a systematic review. Soc 
Sci Med. 2014;109:1–9.
 22. Okoli C, Pawlowski SD. The Delphi method as a research tool: an 
example, design considerations and applications. Inf Manag. 2004;42: 
15–29.
 23. Degeling C, Carter SM, Rychetnik L. Which public and why deliberate? 
A scoping review of public deliberation in public health and health 
policy research. Soc Sci Med. 2015;131:114–121.
 24. Burgess M, O’Doherty K, Secko D. Biobanking in British Columbia: 
discussions of the future of personalized medicine through delibera-
tive public engagement. Pers Med. 2008;5:285–296.
 25. Hoffmann TC, Erueti C, Glasziou P. Poor description of non- 
pharmacological interventions: analysis of consecutive sample of ran-
domised trials. BMJ. 2013;347:f3755.
 26. Bennett P, Smith SJ. Genetics, insurance and participation: how a cit-
izens’ jury reached its verdict. Soc Sci Med. 2007;64:2487–2498.
 27. Bombard Y, Abelson J, Simeonov D, Gauvin FP. Eliciting ethical and 
social values in health technology assessment: a participatory ap-
proach. Soc Sci Med. 2011;73:135–144.
 28. Bombard Y, Abelson J, Simeonov D, Gauvin FP. Citizens’ perspectives 
on personalised medicine: a qualitative public deliberation study. Eur 
J Hum Genet. 2013;21:1197–1201.
 29. Carman KL, Mallery C, Maurer M, et al. Effectiveness of public delib-
eration methods for gathering input on issues in healthcare: results 
from a randomised trial. Soc Sci Med. 2015;133:11–20.
 30. Chafe R, Merali F, Laupacis A, Levinson W, Martin D. Does the public 
think it is reasonable to wait for more evidence before funding inno-
vative health technologies? The case of PET scanning in Ontario. Int J 
Technol Assess Health Care. 2010;26:192–197.
 31. Chafe R, Lauoacis A, Levinson W. Accepting new patients: What 
does the public think about Ontario’s policy? Can Fam Physician. 
2011;57:e68–e73.
 32. Dunkerley D, Glasnes P. Empowering the public? Citizens’ juries and 
the new genetic technologies. Crit Public Health. 1998;8:181–192.
 33. Einsiedel EF, Ross H. Animal spare parts? A Canadian public consulta-
tion on xenotransplantation. Sci Eng Ethics. 2002;8:579–591.
 34. Einsiedel EF. Assessing a controversial medical technology: Canadian 
public consultations of xenotransplantation. Public Underst Sci. 
2002;11:315–331.
 35. Elwood P, Longley M. My health: whose responsibility? A jury decides. 
J Epidemiol Community Health. 2010;64:761–764.
 36. Finney C. Implementing a citizen- based deliberative process on the 
internet: the Buckinghamshire health authority electronic citizens’ 
jury in the UK. Sci Pub Policy. 2000;27:45–64.
 37. Fish RD, Winter M, Oliver DM, Chadwick DR, Hodgson CJ, 
Heathwaite L. Employing the citizens’ jury technique to elicit rea-
soned public judgements about environmental risk: insights from an 
inquiry into the governance of microbial water pollution. J Environ 
Plan Manag. 2012;57:233–253.
 38. Herbison P, Hay-Smith J, Paterson H, Ellis G, Wilson D. Research pri-
orities in urinary incontinence: results from citizens’ juries. J Obstetr 
Gynaecol. 2009;116:713–718.
 39. Hodgetts K, Hiller JE, Street JM, et al. Disinvestment policy and the 
public funding of assisted reproductive technologies: outcomes of 
deliberative engagements with three key stakeholder groups. BMC 
Health Serv Res. 2014;14:204–217.
 40. Iredale R, Longley M. Public involvement in policy- making: the case 
of a citizens’ jury on genetic testing for common disorders. J Consum 
Stud Home Econ. 1999;23:3–10.
 41. Iredale R, Longley M, Thomas C, Shaw A. What choice should we be 
able to make about designer babies? A citizens’ jury of young people 
in South Wales. Health Exp. 2006;9:207–217.
 42. Kashefi E, Mort M. Grounded citizens’ juries: a tool for health activ-
ism. Health Exp. 2004;7:290–302.
 43. Lee YH, Jin DY. An analysis of citizens’ jury on the Korean national 
pandemic response system. Javnost Pub. 2014;21:23–38.
 44. Lenaghan J, New B, Mitchell E. Setting priorities: is there a role for 
citizens’ juries? BMJ. 1996;312:1591–1593.
 45. Longstaff H, Burgess MM. Recruiting for representation in public delib-
eration on the ethics of biobanks. Public Underst Sci. 2010;19:212–224.
 46. McWhirter RE, Critchley CR, Nicol D, et al. Community engagement 
for big epidemiology: deliberative democracy as a tool. J Pers Med. 
2014;4:459–474.
 47. Menon D, Stafinski T. Engaging the public in priority- setting for health 
technology assessment: findings from a citizens’ jury. Health Exp. 
2008;11:282–293.
 48. Molster C, Maxwell S, Youngs L, et al. Blueprint for a deliberative pub-
lic forum on biobanking policy: were theoretical principles achievable 
in practice? Health Exp. 2011;16:211–224.
 49. Moretto N, Kendall E, Whitty J, et al. Yes, the government should tax 
soft drinks: findings from a citizens’ jury in Australia. Int J Environ Res 
Public Health. 2014;11:2456–2471.
 50. Nep S, O’Doherty K. Understanding public calls for labeling of genet-
ically modified foods: analysis of a public deliberation on genetically 
modified salmon. Soc Nat Resour. 2013;26:506–521.
 51. O’Doherty KC, Burgess MM. Engaging the public on biobanks: 
outcomes of the BC biobank deliberation. Public Health Genom. 
2009;12:203–215.
 52. Parkin L, Paul C. Public good, personal privacy: a citizens’ deliberation 
about using medical information for pharacoepidemiological research. 
J Epidemiol Community Health. 2011;65:150–156.
 53. Rogers WA, Street JM, Braunack-Mayer AJ, Hiller JE. Pandemic in-
fluenza communication: views from a deliberative forum. Health Exp. 
2009;12:331–342.
 54. Rychetnik L, Doust J, Thomas R, Gardiner R, MacKenzie G, Glasziou P. 
A community jury on PSA screening: what do well- informed men want 
the government to do about prostate cancer screening – a qualitative 
analysis. BMJOpen. 2014;4:e004682.
 55. Secko DM, Preto N, Niemeyer S, Burgess MM. Informed consent in 
biobank research: a deliberative approach to the debate. Soc Sci Med. 
2009;68:781–789.
     |  637Thomas eT al.
 56. Stafinski T, Devidas M, Yasui Y. Assessing the impact of deliberative 
processes on the views of participants: is it ‘in one ear and out the 
other’? Health Expect. 2012;17:278–290.
 57. Timotijevic L, Raats MM. Evaluation of two methods of deliberative 
participation of older people in food- policy development. Health 
Policy. 2007;82:302–319.
 58. Toni A, von Braun J. Poor citizens decide on the introduction of GMOs 
in Brazil. Biotechnol Dev Monit. 2001;47:7–9.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the support-
ing information tab for this article.
